Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Tell us what YOU think. Take The Body's Visitor Survey!
  
  • Email Email
  • Glossary Glossary

Reyataz (Atazanavir)

The Details

Reyataz (atazanavir or ATV) is a protease inhibitor used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in patients 3 months of age and older. It is listed in the HHS HIV treatment guidelines as part of an alternative regimen for people starting HIV treatment for the first time, when taken in combination with Norvir and Sustiva.

Isentress

Adult single dose (treatment-naive patients): Take 300 mg with Norvir 100 mg once daily OR 400 mg once daily; when coadministered with Sustiva, the dose is 400 mg with Norvir 100 mg. Capsules come in the following strengths: 150 mg, 200 mg and 300 mg.
Adult single dose (treatment-experienced patients): Take 300 mg with Norvir 100 mg once daily; when coadministered with both H2RA and Viread, the dose is 400 mg with Norvir 100 mg.

Restrictions:

  • Take Reyataz with food. Swallow the capsules whole. Do not open the capsules.
  • If you are taking antacids or the anti-HIV medicine Videx or Videx EC, take Reyataz 2 hours before or 1 hour after you take these medicines.
  • Always take Reyataz in combination with other anti-HIV medicines.
  • Women should not breastfeed while on Reyataz.
The Basics
News & Research

  
  • Email Email
  • Glossary Glossary
Advertisement